Consideration of QT/QTc interval data in a phase I study in patients with advanced cancer.
Varterasian
Mary
M
Fingert
Howard
H
Agin
Marilyn
M
Meyer
Mark
M
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002319:Cardiovascular System / Q000187:drug effects*; D017321:Clinical Trials, Phase I as Topic; D003327:Coronary Disease / Q000209:etiology; D004562:Electrocardiography / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D012449:Safety; D013267:Stilbenes / Q000627:therapeutic use*
D000972:Antineoplastic Agents, Phytogenic; D013267:Stilbenes; C058728:fosbretabulin